Where did Prakash Gowd go to school?

Prakash Gowd studied at McGill University (Master of Business Administration - MBA); The University of British Columbia (BSc. Pharmacy); The University of British Columbia (BSc. Zoology).

Prakash Gowd

Investor

Vice President; Interim President & CEO at Toronto Innovation Acceleration Partners

Greater Toronto Area, Canada

About

Prakash Gowd joined TIAP in January 2024 as Vice President and became Interim President & CEO in April 2026. He has over 25 years of experience across biopharma, capital markets, and entrepreneurship, previously serving as COO and Head of Corporate Development at a mental health and psychedelic medicine company and as co-founder of a health technology company, both of which he helped take through public listing or acquisition. Earlier in his career he held biotech equity research and investment banking roles at CIBC World Markets, National Bank Financial, and Canaccord Capital, and he holds an MBA from McGill University plus Pharmacy and Zoology degrees from the University of British Columbia.

Invests in

BiotechDigital HealthHealthtechMental Health

Experience

TIAP - Toronto Innovation Acceleration PartnersInterim Chief Executive Officercurrent2023 — presentToronto, ON
BioSyent IncDirectorcurrent2025 — present
HDAX TherapeuticsDirectorcurrent2024 — present
Appili TherapeuticsDirector & Chair of the Audit Committeecurrent2023 — present
Tailored Genes Inc.Chief Business Officer2023Toronto, Ontario, Canada
FendX Technologies Inc.Director & Chair of the Audit Committee2021 — 2022
NovamindChief Operating Officer & Head of Corporate Development2020 — 2022
Lobo GeneticsCo-Founder, President & Advisor2018 — 2021
CIBC World MarketsExecutive Director, Biotech & Pharma Equity Research2015 — 2018
Isotechnika Pharma Inc.Director & Chair of the Audit Committee2010 — 2013
National Bank Financial & Canaccord CapitalDirector & Senior Analyst, Healthcare & Biotech Equity Research2001 — 2008
GlaxoSmithKline & PSL Consulting GroupPharmaceutical Marketing, Brand Management, Market Research & New Product Development1992 — 2001

Education

McGill UniversityMaster of Business Administration - MBA
The University of British ColumbiaBSc. Pharmacy
The University of British ColumbiaBSc. Zoology

Skills & more

Board LevelVenture FinancingProgram BudgetingMedia RelationsMarketing StrategyPortfolio Management2Healthcare IndustryFiscal ManagementEarly-Stage StartupsEntrepreneurship1Project ManagementPresentation Skills

+12 more

Mergers & Acquisitions (M&A)Business Valuationturnaround managementCorporate FinanceRestructuringClinical TrialsStrategic ConsultingClinical DevelopmentEstablishing RelationshipsTeam LeadershipNegotiationEasily Adaptable

Chartered Director (C.Dir.) — McMaster University

From Prakash's professional profile.

Investments

Board seats

Appili TherapeuticsBioSyentFendX TechnologiesHDAX TherapeuticsIsotechnika Pharma

Per the firm's website.

Colleagues at Toronto Innovation Acceleration Partners

Barry Gee

Director, Public Affairs at Toronto Innovation Acceleration Partners

Chris Adams

Chief Financial Officer at Toronto Innovation Acceleration Partners

Diana Resetca

Manager, Technology & Venture Development at Toronto Innovation Acceleration Partners

Dr. Angela Zhou

Analyst, Technology & Venture Development at Toronto Innovation Acceleration Partners

Dr. Phil Goldbach

Director, Technology and Venture Development at Toronto Innovation Acceleration Partners

Dr. Sohaib Siddiqui

Director, Technology & Venture Development at Toronto Innovation Acceleration Partners

Ido Kaminsky

Director, Technology and Venture Development at Toronto Innovation Acceleration Partners

Michelle Kirkwood

Senior Director, HR Business Partner at Toronto Innovation Acceleration Partners

Frequently asked questions

Who is Prakash Gowd?: Prakash Gowd joined TIAP in January 2024 as Vice President and became Interim President & CEO in April 2026. He has over 25 years of experience across biopharma, capital markets, and entrepreneurship, previously serving as COO and Head of Corporate Development at a mental health and psychedelic medicine company and as co-founder of a health technology company, both of which he helped take through public listing or acquisition. Earlier in his career he held biotech equity research and investment banking roles at CIBC World Markets, National Bank Financial, and Canaccord Capital, and he holds an MBA from McGill University plus Pharmacy and Zoology degrees from the University of British Columbia.
Where does Prakash Gowd work?: Prakash Gowd is Vice President; Interim President & CEO at Toronto Innovation Acceleration Partners.
What does Prakash Gowd invest in?: Prakash Gowd invests in Biotech, Digital Health, Healthtech, Mental Health.
What boards does Prakash Gowd sit on?: Prakash Gowd holds tracked board seats at Appili Therapeutics, BioSyent, FendX Technologies, HDAX Therapeutics, Isotechnika Pharma.
Where did Prakash Gowd go to school?: Prakash Gowd studied at McGill University (Master of Business Administration - MBA); The University of British Columbia (BSc. Pharmacy); The University of British Columbia (BSc. Zoology).

Same school

Also attended McGill University415

Harley FinkelsteinInvestor at Felicis Ventures Mattias LjungmanInvestor at Moonfire Ventures Noubar AfeyanInvestor at Flagship Pioneering David NaultGeneral Partner at Luge Capital Laviva MazharPrincipal at Luge Capital Lisa PurcellInvestor at Third Rock Ventures

+ 409 more

Also attended The University of British Columbia242

Joan MirallesHead of Administration & Valuation at Inveready Technology Investment Group Rares CrisanInvestor at Notable Capital Marianne WuVenture Partner at Congruent Ventures Brendan BakerPartner at Rackhouse Venture Management Lp Ali KashaniVenture Partner at Think+ Ventures Management, Llc Nick FitzInvestor at Juniper Ventures Management, Llc

+ 236 more

Shared employers

Also worked at Appili Therapeutics1

Juliana MuñozAssociate at Amplitude Venture Capital

Also worked at CIBC World Markets28

Austin PringleAnalyst at Congruent Ventures Chris CusinatoAssociate at Odyssey Investment Partners Inshaal QadirAnalyst at Panache Ventures Nolan OlsenCapital Formation at NEW VISTA CAPITAL Enio LazzerCOO and CFO at Espresso Capital Henry O’ConnorIII, General Partner at Multiplier Capital

+ 22 more

Also worked at GlaxoSmithKline & PSL Consulting Group111

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at Medicxi Jeb KeiperInvestor at Third Rock Ventures Jane SuhPrincipal on the AlleyCorp Healthcare team Carol SuhPartner at ARCH Venture Partners Rudina SeseriFounder and Managing Partner at Glasswing Ventures

+ 105 more